| Literature DB >> 23545684 |
Ahad Eshraghian1, Amir A'lam Kamyab.
Abstract
Atorvastatin is a lipid lowering agent that is widely used worldwide. Rhabdomyolysis is a rare but serious side effect that may lead to renal failure and dangerous electrolyte abnormalities in patients with decreased hepatic clearance of atorvastatin. We herein report the case of a patient with liver cirrhosis receiving atorvastatin therapy for ischemic heart disease and hyperlipidemia who developed rhabdomyolysis and acute renal failure.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23545684 DOI： 10.2169/internalmedicine.52.9272
Source DB: PubMed Journal: Intern Med ISSN： 0918-2918 Impact factor: 1.271